HAON Life Sciences is developing innovative cell therapies with primary research targeting a devastating pediatric condition called (HIE).
HAON Life Sciences has raised $11.7M in total funding. The most recent round was Grant. The last funding was announced in April 2025.
HAON Life Sciences's investors include Disruptive Technologies Innovation Fund.
HAON Life Sciences is headquartered in Dublin, Ireland.
HAON Life Sciences is developing innovative cell therapies with primary research targeting a devastating pediatric condition called (HIE).
HAON Life Sciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HAON Life Sciences — Funding & Investors." VCBacked, April 9, 2025, https://www.vcbacked.co/company/haon-life-sciences. Accessed September 10, 2026.
VCBacked. (2025). HAON Life Sciences — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/haon-life-sciences
{{cite web |title=HAON Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/haon-life-sciences |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated